PLASMA CELL DISORDER
Clinical trials for PLASMA CELL DISORDER explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL DISORDER trials appear
Sign up with your email to follow new studies for PLASMA CELL DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin c boost: could it make chemo safer for myeloma patients?
Disease control Recruiting nowThis early-phase trial tests whether high-dose vitamin C, combined with a lower dose of the chemotherapy drug melphalan and a stem cell transplant, is safe and effective for people with relapsed multiple myeloma. The study enrolls 18 adults who have already tried at least three p…
Matched conditions: PLASMA CELL DISORDER
Phase: PHASE1 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New injection site for blood cancer drug could ease patient discomfort
Symptom relief Recruiting nowThis study tests whether giving the drug daratumumab as a shot in the upper thigh works as well as the usual shot in the abdomen for people with plasma cell disorders like multiple myeloma. The goal is to find a less painful or more accessible injection spot. About 30 adults will…
Matched conditions: PLASMA CELL DISORDER
Phase: PHASE1, PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Firefighter blood study seeks to uncover cancer clues
Knowledge-focused Recruiting nowThis study looks at whether firefighters' exposure to hazardous chemicals leads to pre-cancerous changes in their blood. Researchers will collect blood samples from 300 firefighters aged 40-49 with at least 5 years on the job. The goal is to find early markers that might predict …
Matched conditions: PLASMA CELL DISORDER
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New study tracks how CAR-T therapy impacts Seniors' daily lives
Knowledge-focused Recruiting nowThis study observes older patients (60+) receiving standard CAR-T therapy for blood cancers. Researchers track how treatment affects daily activities, thinking skills, and overall quality of life. No extra treatments are given—just careful monitoring to learn more about patient e…
Matched conditions: PLASMA CELL DISORDER
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC